Amcor is making strides with a joint project involving Metsä Group and G Mondini while grappling with a 13.06% decline in total shareholder return over the past year. As it trades at $39.64, the company's financial landscape is further complicated by high leverage of $14.9 billion and recent share price drops. Despite these challenges, Amcor is investing over $35 million in a new healthcare packaging facility in Selangor, aiming to boost local production and implement $260 million in synergies this fiscal year. With plans to increase its quarterly dividend to $0.13 per share, Amcor prepares to announce its fiscal 2026 third-quarter results amid cautious investor sentiment.
“Amcor · has moved forward in · joint project with Metsä Group and G Mondini · true”
“Amcor · worked with · G Mondini on machine compatibility · true”
“Amcor (AMCR) · is trading at · price · $39.64”
“Amcor's share price return · shows a · 1 day decline · 1.56%”
“Amcor's share price return · shows a · 90 day decline · 10.48%”
“Amcor's total shareholder return · points to · 1 year decline · 13.06%”
“Amcor's fair value · sits near · fair value estimation · $5.00”
“Intrinsic Value (DCF) per share · Estimate · intrinsic value · 4.85 dollars”
“Amcor's fair value range · is influenced by · cash flow, dividend commitments and long run profitability assumptions · true”
“Amcor's leverage · is estimated at · high leverage · US$14.9b”
“Amcor · opened · advanced healthcare packaging coating facility · in Subang Jaya, Selangor”
“Amcor · invested · amount · over $35 million USD”
